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Abstract
Background: The tumor necrosis factor-alpha (TNFa) G308A gene polymorphism has been implicated in susceptibility to
essential hypertension (EH), but study results are still controversial.
Objective and Methods: The present meta-analysis is performed to investigate the relationship between the TNFa G308A
gene polymorphism and EH. Electronic databases were searched and seven separate studies on the association of the TNF a
G308A gene polymorphism with EH were analyzed. The meta-analysis involved 1092 EH patients and 1152 controls. The
pooled odds ratios (ORs) and their corresponding 95% confidence interval (CI) were calculated by a fixed or random effect
model.
Results: A significant relationship between the TNFa G308A gene polymorphism and EH was found in an allelic genetic
model (OR: 1.45, 95% CI: 1.17 to 1.80, P=0.0008), a recessive genetic model (OR: 3.181, 95% CI: 1.204 to 8.408, P=0.02), and
a homozygote model (OR: 3.454, 95% CI: 1.286 to 9.278, P=0.014). No significant association between them was detected in
both a dominant genetic model (OR: 1.55, 95% CI: 0.99 to 2.42, P=0.06) or a heterozygote genetic model (OR: 1.45, 95% CI:
0.90 to 2.33, P=0.13).
Conclusion: The TNFa G308A gene polymorphism is associated with EH susceptibility.
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Introduction
There are about one billion essential hypertension (EH) patients
in the world, and the current EH morbidity in China is about
11.8%. Statistical data from the Ministry of Health of the People’s
Republic of China indicate that the incidence of cerebrovascular
diseases increases up to two million cases each year, and 60% of
which are associated with EH. Among EH sufferers, 1.5 million
die of stroke every year. The Framingham heart study has shown
that in the United States, the EH risk in 55-year-old normotension
individuals is 90% throughout their lives.
EH is a common disease influenced by polygenic and
environmental factors. Finding a new gene associated with EH
will help clarify the pathogenesis of EH and provide a new
therapeutic strategy. The pathogenesis of EH is not limited to
cardiovascular areas and is also related to immunology as well as
heredity [1]. Inflammation plays a key role in the development of
such cardiovascular diseases as atherosclerosis, diabetes, and so on
[2]. The association of inflammation with EH has received
increased attention for the past few years.
Tumor necrosis factor-alpha (TNF a), the inflammation promoter, is
secreted primarily by mononuclear phagocyte cells. TNF a
induces endothelial cells to secrete vasoactive substances via the
autocrine or paracrine pattern, which leads to vasorelaxation or
vasoconstriction, and ultimately, to the regulation of blood
pressure (BP) [3]. The TNF a gene is located in the major
histocompatibility complex III region on chromosome 6p21.3.
Recent research has revealed that TNF a gene polymorphisms are
mostly focused on the probable influence of the promoter district
on the expression of the TNFa gene. The TNFa gene
polymorphism is also involved in infectious diseases, metabolic
syndrome, stroke, hyperuricemia, and so on [4–7].
In 2003, Bogdanski et al. [8] found that the serum TNFa level
in EH patients was much higher than in normotensive individuals,
and gradually increased with the EH process. In 2010, Mazor et
al. [9] found a similar phenomenon in mice. The 308
th TNF a
gene promoter can influence TNF a expression at the transcription
level [10]. Although research on TNFa G308A gene polymor-
phism and EH is relatively limited, the results are still controversial
[11–17].
Hence, the present meta-analysis, which involved 2244 subjects,
was performed to generate a valuable conclusion on the
association between the TNFa G308A gene polymorphism and
EH (Supporting Information S1).
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Publication search and inclusion criteria
The included studies were retrieved from the electronic
databases PubMed, Embase, Web of Science, China Biological
Medicine Database, and China National Knowledge Infrastruc-
ture using the search terms ‘‘tumor necrosis factor-alpha,’’
‘‘polymorphism,’’ ‘‘hypertension,’’ ‘‘gene,’’ and ‘‘Chinese’’. The
last research was updated on February 5, 2012.
The inclusion criteria were as follows: a) evaluation of the TNFa
G308A gene polymorphism and EH in a Chinese population, b)
EH diagnosis in accordance with the EH diagnosis requirements
of the World Health Organization established in 1999, c) subjects
had a systolic BP$140 mmHg or a diastolic BP$90 mmHg, and
d) subjects had no secondary hypertension.
Data extraction
All data were collected according to a standard protocol. Studies
that were repeated, of poor research quality, did not meet the
inclusion criteria, and provided little information or insufficient
data were excluded. Table 1 lists the characteristics of the
extracted data, including the name of the first author, publication
date, region, number of genotypes, genotype, study design,
matching criteria, total number of cases, and controls. The study
regions comprised China, Korea, and Argentina. China and
Korea were classified into the Asian subgroup, and Argentina into
the American subgroup.
Statistical analysis
The association between the TNFa G308A gene polymorphism
and EH was compared by the odds ratio (OR) and the
corresponding 95% confidence interval (CI) between the EH
and control groups. The heterogeneity of between-studies was
determined by the Chi-square-based Q-test, and the significance
was fixed at the level P,0.05 [18]. The inconsistency index I
2 was
also calculated to evaluate the variation caused by the heteroge-
neity. A high value of I
2 indicated a higher probability of the
existence of heterogeneity (I
2=0% to 25%, no heterogeneity;
I
2=25% to 50%, moderate heterogeneity; I
2=50% to 75%, large
heterogeneity; and I
2=75% to 100%, extreme heterogeneity). If
there was heterogeneity among the studies, the random-effects
model was used to estimate the pooled OR by the DerSimonian
and Laird method [19]. Otherwise, the pooled OR was estimated
by the fixed-effect model (the Mantel-Haenszel method) [20]. The
significance of the pooled OR was determined by the Z test and
the significance was set at P,0.05. Fisher’s exact test was used to
assess the Hardy-Weinberg equilibrium and the significance was
set at P,0.05. Potential publication bias was estimated using a
funnel plot. Egger’s linear regression test was used to evaluate the
funnel plot asymmetry on the natural logarithmic scale of the OR
(P,0.05 was statistically significant) [21]. The Review Manager
4.2 software and the STATA 11.0 software were used to perform
statistical analyses (StataCorp, College Station, TX). Recessive
genetic and heterozygote models were analyzed by the STATA
11.0 software, and the other models were analyzed by the Review
Manager 4.2 software.
Results
Studies and populations
Seventeen papers were gathered from the literature research,
among which seven papers were eligible based on the study
selection criteria. Of the ten excluded studies, one paper was a
repeated publication, three papers were reviews, and five
manuscripts were unrelated to the TNFa G308A gene polymor-
phism. One paper was excluded because it deviated from the
Hardy-Weinberg equilibrium (Figure 1, Supporting Information
S2). The data of the seven included studies were obtained from
1092 EH patients and 1152 controls from three districts (Table 1).
The ORs differed among the seven studies; some of which
indicated that the A allele increased EH risk, whereas the others
reported no association between the TNFa G308A gene
polymorphism and EH risk. Hence, a composite analysis of the
study results was performed to draw a reasonable conclusion.
Pooled analyses
A significant association between the TNFa G308A gene
polymorphism and EH was found in an allelic genetic model
(OR: 1.45, 95% CI: 1.17 to 1.80, P=0.0008, Pheterogeneity=0.10),
a recessive genetic model (OR: 3.181, 95% CI: 1.204 to 8.408,
P=0.02, Pheterogeneity=0.417), and a homozygote model (OR:
3.454, 95% CI: 1.286 to 9.278, P=0.014, Pheterogeneity=0.467).
The results from the three genetic models were positive and the
heterogenetity between the invidual studies did not exist which
indicated that there was an intensively positive association between
TNFa 308A allele and EH risk.
No significant association between them was detected in both a
dominant genetic model (OR: 1.55, 95% CI: 0.99 to 2.42,
P=0.06, Pheterogeneity=0.003) or a heterozygote genetic model
(OR: 1.45, 95% CI: 0.90 to 2.33, P=0.13, Pheterogeneity=0.001)
Table 1. Characteristics of the investigated studies of the association between the tumor necrosis factor-alpha G308A gene
polymorphism and essential hypertension.
Author Year Region Ethnicity EH Control sample size P value
GG GA AA G A GG GA AA G A
Sheu WH [11] 2001 China Asian 190 42 3 422 48 207 38 1 452 40 235/246 0.59
Li H [12] 2003 China Asian 192 23 3 407 29 173 22 0 368 22 218/195 0.40
Wu XB [13] 2004 China Asian 90 24 0 204 24 99 15 0 213 15 114/114 0.45
Yoo CS [14] 2007 Korea Asian 78 9 0 165 9 63 16 0 142 16 87/79 0.32
Guo LW [15] 2009 China Asian 102 28 0 232 28 174 21 2 369 25 130/197 0.15
Peng CY [16] 2011 China Asian 209 29 8 447 45 186 22 0 394 22 246/208 0.42
Sookoian S [17] 2005 Argentina American 42 18 2 102 22 96 15 2 207 19 62/113 0.14
Abbreviations: sample size: EH/control.
doi:10.1371/journal.pone.0035408.t001
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genetic model was negative, the P value was 0.06 which suggested
that the association was marginal between them. Supporting that
the sample size was further expanded, the association between
TNFa 308A allele and EH risk might be positive. Similarly, the
same result might also be deduced by the heterozygote genetic
model in the future study.
Bias diagnostics
The publication bias of the included studies was assessed by the
funnel plot and Egger’s test. The funnel plot showed no apparent
evidence of publication bias (Figure 5). There was also no
significant difference in the Egger’s test for the allelic genetic
model, which suggested that the probability of publication bias was
low in the present meta-analysis (T=0.28, P=0.792).
Discussion
The present study suggested a significant association between
the TNFa G308A gene polymorphism and EH in an allelic genetic
model (OR: 1.45), a recessive genetic model (OR: 3.181), and a
homozygote genetic model (OR: 3.454). The A allele of the TNFa
G308A gene may be the susceptibility gene for EH. This result was
the strength of this meta-analysis.
EH is one of the principally harmful disorders to public health.
EH morbidity gradually increases annually, and the EH onset age
becomes younger on the average. Apart from heredity, dietary,
psychological, and neuroendocrinal factors, inflammation also
plays an important part in the EH mechanism [22]. EH is a
genetic heterogeneity disease, and the genetic factor contributes
30% to 50% to the variation in BP [23]. Increased serum
inflammatory factor levels of TNFa, interleukin-6, and adhesion
molecules suggest that inflammation has an important function in
the EH process [8].
Figure 1. Flow diagram of articles selection process for TNF a G308A gene polymorphism and EH risk meta-analysis.
doi:10.1371/journal.pone.0035408.g001
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effect on endothelial cells depending on the dosage. At low
concentration levels, TNF a is a short-distance regulatory factor
that can induce target cells to produce cytokines and antibodies. At
high concentration levels, TNFa can enter the blood and exhibit
hormone-like effects. Increased TNFa exerts an immediate
cytotoxic effect by facilitating neutrophilic granulocyte degranu-
lation, oxidative metabolism, and accelerated lipid peroxidation. It
can destroy the structural integrity and function of endothelial
cells, causing an imbalance in endothelial cells that secrete active
substances. Decreased synthesis and release of vasodilators as nitric
oxide and increased secretion of vasoconstrictors as endothelin and
prostaglandin indirectly expedite vasoconstriction as well as
elevate peripheral resistance and BP. A low perfusion condition
caused by the capillary contraction of the EH target organ also
ensues [24].
The A allele of the TNFa G308A gene increases TNFa
transcription activity and the serum TNF a level. This allele has
also been associated with obesity, type 2 diabetes mellitus,
coronary artery disease, serum C reactive protein, and insulin
resistance [7]. The present meta-analysis confirms that the A allele
of the TNFa G308A gene increases EH susceptibility.
The divergence among the different research results may be due
to the following limitations:
(a) Ethnic differences. In 2001, Ito et al. [25] found that TNF-
alpha may play a role in modulating BP and low-density-
lipoprotein cholesterol in Japanese women. However, in
2002, Krikovszky et al. [26] reported that the TNF-alpha-
308A allele carrier state appears to be associated with the
low systolic and diastolic BP values in diabetic adolescents in
Hungary. In 2007, Yoo et al. [14] found that the TNF-alpha-
308G allele carrier is associated with increased EH risk in
Koreans. In China, Guo [15] and Peng et al. [16] found that
a positive relationship between EH and the TNF-alpha-308A
allele. Sookoian et al. also confirmed this point in Argentina
[17]. As the ethnic differences among the individual studies
existed, the population was devided into two subgroups as
Table 2. Summary of meta-analysis of association of tumor necrosis factor-alpha G308A and EH risk.
Pooled OR (95% CI) P value Number EH size control size Pheterogeneity
Allelic gentic model 1.45(1.17–1.80) 0.0008
* 7 1092 1152 0.10
Dominant genetic model 1.55(0.99–2.42) 0.06 7 1092 1152 0.003
*
Recessive genetic model 3.181(1.204–8.408) 0.02
* 7 1092 1152 0.417
Homozygote model 3.454(1.286–9.278) 0.014
* 7 1092 1152 0.467
Heterozygote model 1.45(0.90–2.33) 0.13 7 1092 1152 0.001
*
Abbreviations: CI: confidence interval; OR: odds ratio;Allelic gentic model: distribution of A allelic frequency;Dominant genetic model: GA+AA/GG; Recessive genetic
model:AA/GA+GG; Homozygote model:AA/GG; Heterozygote model:GA/GG;Number: literature number;
*P,0.05.
doi:10.1371/journal.pone.0035408.t002
Figure 2. Forest plot of essential hypertension associated with tumor necrosis factor-alpha (TNF a) G308A gene polymorphism under
the allelic genetic model (distribution of A allelic frequency of TNF a G308A gene).
doi:10.1371/journal.pone.0035408.g002
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respectively.
(b) Geographic isolation. In the seven studies included in the
current meta-analysis, the pressure of natural selection
caused an idiopathic gene polymorphism distribution
structure. This phenomenon can be attributed to the fact
that the research subjects in the seven studies came from
different districts.
Figure 3. Forest plot of essential hypertension associated with tumor necrosis factor-alpha (TNF a) G308A gene polymorphism under
the dominant genetic model (GA+AA vs. GG).
doi:10.1371/journal.pone.0035408.g003
Figure 4. Forest plot of essential hypertension associated with tumor necrosis factor-alpha (TNF a) G308A gene polymorphism under
the heterozygote model (GA vs. GG).
doi:10.1371/journal.pone.0035408.g004
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size was relatively small and the results may be unclear.
Increased sample size is recommended in further research.
Finally, the present meta-analysis suggests that the frequency
distribution of the A allele of the TNFa G308A gene may be
predisposed to EH. Due to the aforementioned limitations, further
investigations should be conducted to verify these findings.
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